January 11, 2018
Novartis appoints new Oncology CEO
Novartis has appointed Elizabeth Barrett, currently Global President Oncology at Pfizer, Inc., as the CEO Novartis Oncology and a member…
Pharmaceuticals, Biotechnology and Life Sciences
Author: Dino Mustafić
January 11, 2018
Advanced biotech startup touts ground-breaking medical research, deep ties to New York State
Hemogenyx Pharmaceuticals, the biotechnology company developing novel therapies to transform bone marrow, or blood stem cell, transplantation for the treatment…
January 10, 2018
AstraZeneca’s Fasenra cleared in Europe (EU)
The European Commission (EC) has approved AstraZeneca’s Fasenra as an add-on maintenance treatment in certain adult patients with severe eosinophilic…
January 10, 2018
Amryt to deliver Lojuxta in Central and Eastern Europe via GryNumber Health
Amryt has paved its way for marketing for Lojuxta by signing a deal with with GryNumber Health. The exclusive distribution…
January 10, 2018
Basilea cashes $3M as it expands Asia Pacific deal for Cresemba with Pfizer
Basilea Pharmaceutica and Pfizer have extended their license agreement for Basilea’s antifungal Cresemba to China and sixteen countries in Asia…
January 10, 2018
Vertex cleared to extend marketing for Orkambi (CF) in Europe
Vertex Pharmaceuticals got European Commission’s grant to extend the Marketing Authorization for ORKAMBI, the first medicine to treat the basic…
January 9, 2018
Novartis moves with clinical trial of Cosentyx vs others, recruiting patients
Novartis has initiated SURPASS, a head-to-head clinical trial of Cosentyx (secukinumab) versus proposed biosimilar adalimumab in ankylosing spondylitis (AS). SURPASS…
January 9, 2018
BASF and CTIBiotech announce first results of 3D human sebaceous glands technology for skin care applications
BASF Care Creations and the Cell Therapy Research Institute CTIBiotech presented the initial results of their joint research on 3D…
January 9, 2018
New Tamper Evident Labeller from LSS
LSS Labelling Systems Scandinavia, a Denmark-based supplier of labelling solutions will launch a new Tamper Evident labelling machine for the pharmaceutical industry at…
January 9, 2018
BD to repurchase its 3.000% notes due 2026
BD has started an offer to repurchase all of its outstanding 3.000% Notes until May 15, 2026 that were issued…